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Abstract
Extracorporeal membrane oxygenation is rapidly becoming a preferred therapy for
short-term hemodynamic support in cardiogenic shock, along with the use of
devices such as Impella (Abiomed, Andover, MA). The two together can create
unique hemodynamics resulting in altered presentation of common hemodynamic
conditions such as tamponade. We present a case of a patient with fulminant
myocarditis requiring veno-arterial extracorporeal membrane oxygenation and
Impella support. The patient later developed a pericardial effusion with atypical
tamponade physiology, which masked the left ventricular systolic function
recovery. We further highlight the complex hemodynamics of cardiac tamponade
in patients with such mechanical circulatory support and its implications on
echocardiography.
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Background
Although extracorporeal membrane oxygenation (ECMO) has been available for
over 40 years, used primarily in neonatology, over the past decade the technology
has gained momentum in adult cardiology. ECMO is fast becoming a preferred
device for short-term hemodynamic support in patients with cardiogenic shock, as
seen by the exponential growth in the number of ECMO centers which has
increased by 133% in the last decade.1
Early use of veno-arterial ECMO (V-A ECMO) has shown the promising trend of
increased survival in patients with fulminant myocarditis presenting with
cardiogenic shock .2-5 A common drawback of this modality is an increase in left
ventricular (LV) afterload, resulting in delayed myocardial recovery, pulmonary
congestion, and other adverse sequalae. Several interventions can be used in
conjugation with V-A ECMO to unload the LV, thereby avoiding complications .6,7
One of the options of venting the LV is facilitating the forward flow with another
device such as Impella (Abiomed, Andover, MA). The combination of two means of
mechanical circulatory support (MCS) creates new hemodynamic patterns which
may alter the presentation of common hemodynamic conditions such as
tamponade. We describe a case of a young patient presenting with fulminant
myocarditis leading to cardiogenic shock who was treated with a combination of VA ECMO and Impella (ECPELLA). The patient developed pericardial effusion with
atypical tamponade physiology which masked the recovery of LV systolic function.
We have also highlighted the complex hemodynamics of cardiac tamponade in a
patient with dual MCS and its implication on echocardiographic diagnostic
approach.

Case Report
A 25-year-old, previously healthy female presented to the emergency room with a
four-day history of nausea, vomiting, abdominal and central chest pain, and a fever
of up to 102 °F. She developed ventricular tachycardia, cardiac arrest, and
underwent cardiopulmonary resuscitation with return of spontaneous circulation in
less than two minutes. The patient was intubated for airway protection. Her
echocardiogram showed an LV ejection fraction (LVEF) of less than 10%. As she
remained in cardiogenic shock, she was placed on V-A ECMO and Impella CP
support. The ECMO flow was 4.5 L/min at a speed of 3590 revolutions per minute,
and the Impella flow was 2.5 L/min at P6. The patient was also on epinephrine
(0.05 mcg/kg/min) and milrinone (0.25 mcg/kg/min).
On Day 2 of the patient’s hospitalization, her echocardiogram showed moderate
pericardial effusion without any echocardiographic features of cardiac tamponade
such as right ventricular or right atrial collapse, plethoric inferior vena cava, or
excessive mitral/tricuspid inflow variability (Figure 1).
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Figure 1: Transthoracic echocardiogram 4-chamber view prior to pericardial
drainage (Video 1).
Although unclear, the etiology of pericardial effusion could be due to viral
myopericarditis or ventricular perforation during placement of the Impella CP. The
patient’s blood pressure on Day 2 was 74/69 mmHg. The patient underwent right
heart catheterization and endomyocardial biopsy. Percutaneous drainage of
pericardial effusion was attempted, but unsuccessful.
The patient’s right heart pressures were as follows: right atrium 8 mmHg, right
ventricle 29/3/7 mmHg, pulmonary artery 21/12 mmHg, pulmonary capillary wedge
pressure 11 mmHg. The patient’s vasopressor requirement was increasing, with
addition of vasopressin at 0.04 units/min. It was decided to drain the pericardial
effusion surgically. The transesophageal echocardiography showed large
pericardial effusion with floating of the heart with an estimated LVEF of around
15% (Figures 2). During the drainage there was an immediate gush of blood
suggesting high intra pericardial pressure. The pericardial fluid was sanguineous,
and a clot was also removed. Echocardiography showed a mild improvement of LV
systolic function (Figures 3 and 4).

Figure 2. Transesophageal echocardiogram (transgastric view) showing the
significant pericardial effusion build-up. A. Papillary muscle level B (Video 2A).
Apex of the heart (Video 2B).
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Figure 3. Transesophageal echocardiogram showing slight improvement in left
ventricular function immediately after pericardial effusion drainage (Video 3).

Figure 4. Transthoracic echocardiogram the next day after pericardial effusion
drainage, now with improving left ventricular function (Video 4).
There was no immediate change in ECMO or Impella flow post-drainage; however,
hemodynamics improved significantly with decreasing pressor requirements
approximately 6 hours post-drainage. Epinephrine and vasopressin were reduced
to 0.02 mcg/kg/min and 0.03 units/min, respectively. The patient was off
vasopressin 24 hours post-drainage.
The pericardial fluid showed mesothelial and mixed inflammatory cells, blood, and
fibrin. The patient’s cardiac biopsy was consistent with acute lymphocytic
myocarditis. The patient tested positive for SARS-CoV-2 and was treated with
remdesivir (5-day course), high-dose methylprednisolone (3-day course), and
convalescent plasma (2 doses). There was impressive recovery of LV function the
next day. The patient made a complete recovery and was discharged home in less
than 2 weeks.
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Discussion
In this case report, we describe a patient who became hemodynamically unstable
while being supported on both V-A ECMO and Impella, which lead to a suspicion
of cardiac tamponade. Although no clinical or echocardiographic signs of
tamponade were present, the drainage of pericardial fluid resulted in immediate
hemodynamic stabilization, confirming the diagnosis of tamponade.
The classical Beck triad, described in 1935, remains the mainstay of our
understanding and clinical diagnosis of pericardial tamponade. The triad consists
of three medical signs including low blood pressure, distended neck veins, and
muffled heart sounds, with the main pathophysiological phenomena of increased
central venous pressure.8 Paradoxically, in a patient where ECMO is working
optimally, blood pressure is usually maintained or artificially supported by
vasopressors, central venous pressure is within normal limits, and heart sounds
are replaced by machinery hum. Pulsus paradoxus, another cornerstone of
physical exam-based diagnosis of tamponade, is no longer present. Pulsus
paradoxus reflects decreased systolic output on inspiration while the right
ventricular filling increases because of increased interventricular dependence. In a
patient supported by V-A ECMO and Impella, forward flow is much less dependent
on the ventricular filling/contraction and is mostly determined by ECMO and
Impella, both providing a continuous (non-pulsatile) flow. This unique physiology of
a mechanically supported patient can mask the presentation of acute cardiac
tamponade, which is difficult to diagnose or even suspect if the traditional bed side
teaching principles are applied in an ECMO patient.
It is commonly said that tamponade is a clinical diagnosis; however, in reality,
echocardiographic signs often precede the clinical signs. This is especially true in
the intensive care setting in patients who are sedated, on a ventilator, and unable
to report any symptoms. Echocardiography is the test of choice when the
diagnosis of tamponade is clinically suspected. Significant progress and
standardization has been made especially in Doppler interpretation of cardiac
tamponade physiology, the hallmark of which is an exaggerated inspiratory
decrease in mitral valve inflow. This is an echocardiographic equivalent of pulsus
paradox. Echocardiographically this has been described as interventricular
interdependence and interpretated as exaggerated changes in mitral and tricuspid
Doppler inflow and M mode finding of enhanced reciprocal changes in ventricular
dimensions.9
The physiology of a closed ECMO circuit is briefly reviewed for a better
understanding of the hemodynamics of cardiac tamponade in patients with
mechanical ventilator support. The V-A ECMO circuit withdraws deoxygenated
blood from the right atrium or central vein with a non-pulsatile pump and directs it
to the membrane oxygenator and then to a systemic artery via an outflow cannula,
thus replacing the heart and lungs.1 As seen with this circuit, the physiology of
interventricular interdependence is replaced by a mechanical non-pulsatile pump
and oxygenator, therefore making the diagnosis of cardiac tamponade on the
basis classical signs and symptoms of pulsus paradox and interventricular
interdependence unreliable.
The positive pressure ventilation is known to mask the pulsus paradoxus and in
combination with ECMO support will further augment the masking of this
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tamponade physiology. The LV Impella unloads the left ventricle and decreases
the left ventricular end diastolic pressure, which intuitively should help in
recognition of pulsus paradox. However, it also provides a continuous flow which
masks any potential variability coming from the native left ventricular contractions.
It is important to understand that cardiac output in a patient on MCS consists of
two parts: the support provided by the devices such as ECMO and Impella, and
the output coming from the native heart. In our patient, who had a combined
ECMO and Impella flow of 7 L/min, her own heart with a LVEF < 20% was only
minimally contributing.
The hemodynamic performance of the LV in cardiogenic shock is best described
by pressure volume loop (PV loop). Independent of underlying etiology, the LV
contractility (reflected by Emax and defined as the maximum slope at the end
systolic PV point) is reduced and LV end diastolic pressure is increased.1 In this
PV loop the exact hemodynamics on a patient on V-A ECMO, LV Impella, and
mechanical ventilation has not been described before in our literature search.
At the molecular level, the phenomena of myocardial stunning in myocarditis has
been described and is implicated due to increased reactive oxygen species
production, with a decreased sensitivity of myofilaments to calcium and
dysfunction of excitation coupling phenomena.10 The immediate recovery of LV
function after relief of pericardial tamponade in this patient may have some
underlying stunning.
Pericardial tamponade has been described in pediatric and adult ECMO patients.
However, this is limited to a few case reports.11,12 Our case is unique, as
pericardial tamponade in complex scenario such as the combined use of ECMO
and Impella has not been described in the literature to our knowledge.

Conclusion
Several takeaway messages can be made from this case:
1. The patient on ECPELLA circuit shows atypical features of cardiac
tamponade. Classical signs of pulsus paradox and interventricular
interdependence are absent, which can delay the diagnosis of pericardial
tamponade if existing clinical, hemodynamic, and echocardiographic
criteria are applied.
2. Echocardiographically the use of Doppler criteria and inferior vena cava
plethora can be misleading. The only findings could be demonstration of
chamber invagination signs and large effusions with swinging motion which
usually are seen late in the continuum of cardiac tamponade.
3. Invasive hemodynamics using right heart catheter cannot be completely
relied upon, in view of the altered physiology in the MCS.
4. Limited echocardiography should be part of daily exams in patients on
MSC, to assess the accumulation of pericardial fluid. The significant
improvement in handheld devices can be utilized in intensive care unit
settings as a standard protocol.
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5. We recommend considering draining any substantial pericardial effusion in
patients that are on advanced MCS. It is imperative to remember that the
traditional signs of pericardial tamponade may not be reliable in patients
supported on MCS.
6. Further research is needed in animal or computer models to assess the
effect of tamponade physiology on PV loop in patients on these devices,
with the potential to improve our understanding of treating these complex
patients.
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